Structure of C3b reveals conformational changes that underlie complement activity
By B. Janssen, A. Christodoulidou, A. McCarthy, John D Lambris, P. Gros. 2006
394 citations recorded by the source corpus.
Subfields: Hematology, Immunology, Physiology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Pavel V. Afonine
- Paul D. Adams
- Nigel W. Moriarty
- T. C. Terwilliger
- D. Liebschner
- Nathaniel Echols
- R. Grosse-Kunstleve
- J. Headd
Citations in the corpus
- Towards automated crystallographic structure refinement with phenix.refine (2012, background): “…al., 2007), 1yi5 (Bourne et al., 2005), 2wjx (Clayton et al., 2009), 3eob (Li et al., 2009), 1av1 (Brouillette & Anantharamaiah, 1995), 3bbw (Qiu et al., 2008) and 2i07 (Janssen et al., 2006) were selected because their published R factors are much higher than expected (Urzhumtseva et al., 2009).”
- Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (2007, background): “Recent studies have delineated the structure of C3 and C3 fragments and provided important insights into their functio”